Association of inferior division MCA stroke location with populations with atrial fibrillation incidence - Kim, Ganghyun; Vitti, Emilia; Stockbridge, Melissa D.; Hillis, Argye E.; Faria, Andreia V. (medRxiv, 2021)
Background and Aim Anatomical features of Middle Cerebral Artery (MCA) bifurcation favors larger emboli entering the inferior rather than superior division. As cardiac source emboli are on average larger than arterial source emboli, we hypothesize that patients with atrial fibrillation have infarcts that involve more temporal and parietal lobes than frontal lobes.Methods From 1,849 patients admitted with evidence of acute or early subacute ischemic stroke on diffusion-weighted MRI (DWI), 482 affected exclusively the “lobar” MCA (sparing the lenticulostriates). They were classified as “frontal predominant” (n=105) or “temporoparietal predominant” (n=197) if at least 75% of the infarct affected the frontal lobe or the temporal and parietal lobes, respectively. Differences between stroke location (frontal or temporoparietal), sex, and race were analyzed by Chi-square test. Results: Men were more likely than women, and white people were more likely than black people to have temporoparietal strokes versus frontal strokes. Patients with confirmed diagnosis of atrial fibrillation have more temporoparietal strokes, compared to frontal strokes.Conclusion MCA ischemic strokes occur more often in temporoparietal areas in men and in white patients, populations with known elevated incidence of atrial fibrillation. Patients with confirmed diagnosis of atrial fibrillation have more temporoparietal strokes, compared to frontal strokes. Results align with the hypothesis that large emboli (mostly from cardiac source) are more likely to cause temporoparietal strokes in the MCA territory, compared to frontal strokes. This association can help guide search for the most likely etiology of infarcts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported in part by the National Institute of Deaf and Communication Disorders,NIDCD, through R01 DC05375, R01 DC015466, P50 DC01466Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We have complied with all relevant ethical regulations and the guidelines of the Johns Hopkins Institutional Review Board, that approved the present study (IRB00290649)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that supports this study is available in Zenodo https://doi.org/10.5281/zenodo.5722425 https://doi.org/10.5281/zenodo.5722425